price
SV
NASDAQ · SVRA
Savara Inc.
Healthcare · Biotechnology
$4.73
Up+$0.02 (+0.42%)
Updated Nov 3, 2026, 9:15 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.41B
- P/E ratio
- -13.6
- Dividend yield
- 0.00%
- 52-week range
- $4.13 – $6.48
- Volume
- 1.78M
- Avg. volume
- 1.96M
Price performance · SVRA
SVRA price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
SVRA closed at $4.73 after 21 trading sessions, down 1.05% for the selected period.
- Last close
- $4.73
- Period change
- -1.05%
- Period low
- $4.22
- Period high
- $5.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $4.83 | $4.91 | $4.67 | $4.73 | 1.78M |
| Oct 30, 2026 | $4.88 | $4.97 | $4.7498 | $4.82 | 1.41M |
| Oct 29, 2026 | $5.05 | $5.135 | $4.915 | $4.95 | 1.74M |
| Oct 28, 2026 | $4.82 | $5.05 | $4.775 | $5.02 | 1.79M |
| Oct 27, 2026 | $4.49 | $4.905 | $4.45 | $4.86 | 3.59M |
| Oct 26, 2026 | $4.335 | $4.54 | $4.216 | $4.52 | 3.45M |
| Oct 23, 2026 | $4.52 | $4.58 | $4.13 | $4.22 | 2.83M |
| Oct 22, 2026 | $4.65 | $4.75 | $4.45 | $4.54 | 2.71M |
| Oct 21, 2026 | $4.79 | $4.945 | $4.66 | $4.67 | 2.09M |
| Oct 20, 2026 | $4.64 | $4.99 | $4.60 | $4.76 | 4.42M |
| Oct 19, 2026 | $4.53 | $4.705 | $4.495 | $4.63 | 1.56M |
| Oct 16, 2026 | $4.75 | $4.77 | $4.44 | $4.45 | 2.24M |
| Oct 15, 2026 | $4.76 | $4.90 | $4.72 | $4.74 | 1.69M |
| Oct 14, 2026 | $4.71 | $4.82 | $4.65 | $4.76 | 2.57M |
| Oct 13, 2026 | $4.84 | $5.02 | $4.76 | $4.78 | 3.74M |
| Oct 12, 2026 | $4.93 | $5.00 | $4.81 | $4.84 | 1.31M |
| Oct 9, 2026 | $4.82 | $4.975 | $4.81 | $4.92 | 1.53M |
| Oct 8, 2026 | $4.85 | $4.92 | $4.635 | $4.83 | 2.52M |
| Oct 7, 2026 | $4.74 | $5.05 | $4.69 | $4.88 | 2.42M |
| Oct 6, 2026 | $4.82 | $4.84 | $4.60 | $4.65 | 2.29M |
| Oct 5, 2026 | $4.85 | $4.915 | $4.71 | $4.78 | 2.86M |
Latest SVRA news
The latest Smart Investors Daily articles mentioning SVRA.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…